Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 48 for Clinical Genomics

Edit search filters
  1. A Study to Evaluate Patient Experience and Satisfaction with Predictive Genomic Testing Ordered Through SL3

    Rochester, MN

  2. North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

    Rochester, MN

  3. A Study to Establish a Patient Clinical and Genetic Information Database to Better Characterize Symptoms and Causes of Angelman Syndrome

    Rochester, MN

  4. Clinical and Basic Investigations into Congenital Disorders of Glycosylation

    Jacksonville, FL, Rochester, MN

  5. Natural History Study Protocol in PMM2-CDG (CDG-Ia)

    Rochester, MN

  6. Hyperammonemia in Patients undergoing Roux-en-Y Gastric Bypass Surgery

    Rochester, MN

  7. A Study to Evaluate Immune Regulation at the Point Where Maternal Genes and Fetus Genes Meet in the Human Placenta

    Rochester, MN

  8. Development of Skeletal Muscle Fibers from Patient-Derived Induced Pluripotent Stem Cells (iPSCs)

    Rochester, MN

  9. A Study to Assess the Natural History and Routine Clinical Management of Congenital Disorders of Glycosylation

  10. Microbiome on Neckties from Hospital Staff

    Rochester, MN

.

Mayo Clinic Footer